Di, D.; Dileepan, M.; Ahmed, S.; Liang, Y.; Ly, H.
Recombinant SARS-CoV-2 Nucleocapsid Protein: Expression, Purification, and Its Biochemical Characterization and Utility in Serological Assay Development to Assess Immunological Responses to SARS-CoV-2 Infection. Pathogens 2021, 10, 1039.
https://doi.org/10.3390/pathogens10081039
AMA Style
Di D, Dileepan M, Ahmed S, Liang Y, Ly H.
Recombinant SARS-CoV-2 Nucleocapsid Protein: Expression, Purification, and Its Biochemical Characterization and Utility in Serological Assay Development to Assess Immunological Responses to SARS-CoV-2 Infection. Pathogens. 2021; 10(8):1039.
https://doi.org/10.3390/pathogens10081039
Chicago/Turabian Style
Di, Da, Mythili Dileepan, Shamim Ahmed, Yuying Liang, and Hinh Ly.
2021. "Recombinant SARS-CoV-2 Nucleocapsid Protein: Expression, Purification, and Its Biochemical Characterization and Utility in Serological Assay Development to Assess Immunological Responses to SARS-CoV-2 Infection" Pathogens 10, no. 8: 1039.
https://doi.org/10.3390/pathogens10081039
APA Style
Di, D., Dileepan, M., Ahmed, S., Liang, Y., & Ly, H.
(2021). Recombinant SARS-CoV-2 Nucleocapsid Protein: Expression, Purification, and Its Biochemical Characterization and Utility in Serological Assay Development to Assess Immunological Responses to SARS-CoV-2 Infection. Pathogens, 10(8), 1039.
https://doi.org/10.3390/pathogens10081039
